Meropenem
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
MEROPENEM
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study
A porous g-C3N4 nanosheets containing nitrogen defects for enhanced photocatalytic removal meropenem: Mechanism, degradation pathway and DFT calculation